BioRestorative Therapies files to sell 2.51M shares of common stock for holders

20d ago, source: Hosted on MSN

BioRestorative Therapies (NASDAQ:BRTX) filed a prospectus related to the offer and sale of up to 2,513,686 shares of common stock by the selling securityholders. This prospectus is not an offer to ...

BioRestorative Therapies Inc (BRTX) Shares Rise Despite Market Challenges

7d ago, source: newsheater

Silva Francisco, the VP of Research and Development of BioRestorative Therapies Inc, purchase 1,708 shares at $1.16 during a trade that took place back on Apr 08 ’24, which means that Silva Francisco ...

Why BioRestorative Therapies Is Rising In Pre-market?

7d ago, source:

BioRestorative Therapies, Inc. (BRTX) reported that the FDA has cleared an important amendment to the protocol of the ongoing phase 2 ...

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

22d ago, source: Business Insider

MELVILLE, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...

BioRestorative Therapies partners with Galen Patient Recruitment

on MSN ago, source:

BioRestorative Therapies (NASDAQ:BRTX) announced a collaboration with Galen Patient Recruitment, which is expected to help ...

BioRestorative Therapies Inc BRTX

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioRestorative Therapies, Inc: BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

7d ago, source:

Amendment replaces saline injections with sham injections in the control group - MELVILLE, N.Y., April 16, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the ...

BioRestorative Therapies Inc BRTX

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

22d ago, source: Stockhouse

MELVILLE, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the ...

Why BioRestorative Therapies Is Rising In Pre-market?

7d ago, source: Nasdaq

(RTTNews) - BioRestorative Therapies, Inc. (BRTX) reported that the FDA has cleared an important amendment to the protocol of the ongoing phase 2 study investigating the use of BRTX-100 ...

BioRestorative Therapies Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...